Noncontrast myocardial T1 mapping using cardiovascular magnetic resonance for iron overload

To explore the use and reproducibility of magnetic resonance‐derived myocardial T1 mapping in patients with iron overload.

[1]  S. Sheth.  Iron chelation: an update , 2014, Current opinion in hematology.

[2]  D. Pennell,et al.  In vivo comparison of myocardial T1 with T2 and T2* in thalassaemia major , 2013, Journal of magnetic resonance imaging : JMRI.

[3]  D. Pennell,et al.  Cardiovascular function and treatment in β-thalassemia major: a consensus statement from the American Heart Association. , 2013, Circulation.

[4]  S. K. White,et al.  Identification and Assessment of Anderson-Fabry Disease by Cardiovascular Magnetic Resonance Noncontrast Myocardial T1 Mapping , 2013, Circulation. Cardiovascular imaging.

[5]  M. Robson,et al.  Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. , 2013, JACC. Cardiovascular imaging.

[6]  David A Bluemke,et al.  Modified Look‐Locker T1 evaluation using Bloch simulations: Human and phantom validation , 2013, Magnetic resonance in medicine.

[7]  S. K. White,et al.  Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI , 2013, Journal of Cardiovascular Magnetic Resonance.

[8]  Stefan Neubauer,et al.  Myocardial Tissue Characterization Using Magnetic Resonance Noncontrast T1 Mapping in Hypertrophic and Dilated Cardiomyopathy , 2012, Circulation. Cardiovascular imaging.

[9]  Peter Kellman,et al.  Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method , 2012, Journal of Cardiovascular Magnetic Resonance.

[10]  Steffen Ringgaard,et al.  Assessment of intramyocardial hemorrhage by T1-weighted cardiovascular magnetic resonance in reperfused acute myocardial infarction , 2012, Journal of Cardiovascular Magnetic Resonance.

[11]  M. Robson,et al.  Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance , 2012, Journal of Cardiovascular Magnetic Resonance.

[12]  A. Flett,et al.  Characterising the myocardial interstitial space: the clinical relevance of non-invasive imaging , 2012, Heart.

[13]  Richard B. Thompson,et al.  T2-dependent errors in MOLLI T1 values: simulations, phantoms, and in-vivo studies , 2012, Journal of Cardiovascular Magnetic Resonance.

[14]  Dudley J Pennell,et al.  On T2* Magnetic Resonance and Cardiac Iron , 2011, Circulation.

[15]  S. Raman,et al.  Impaired myocardial perfusion reserve and fibrosis in Friedreich ataxia: a mitochondrial cardiomyopathy with metabolic syndrome. , 2011, European heart journal.

[16]  D. Pennell,et al.  Low prevalence of fibrosis in thalassemia major assessed by late gadolinium enhancement cardiovascular magnetic resonance , 2011, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[17]  M. Cheitlin.  Iron Overload Cardiomyopathy: Better Understanding of an Increasing Disorder , 2011 .

[18]  Stefan Neubauer,et al.  Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold , 2010, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[19]  D. Pennell,et al.  Myocardial T2* is not affected by ageing, myocardial fibrosis, or impaired left ventricular function , 2010, Journal of magnetic resonance imaging : JMRI.

[20]  G. Adam,et al.  Distribution of cardiac iron measured by magnetic resonance imaging (MRI)‐R*2 , 2010, Journal of magnetic resonance imaging : JMRI.

[21]  Mark Fogel,et al.  International reproducibility of single breathhold T2* MR for cardiac and liver iron assessment among five thalassemia centers , 2010, Journal of magnetic resonance imaging : JMRI.

[22]  J. Wood.  History and current impact of cardiac magnetic resonance imaging on the management of iron overload. , 2009, Circulation.

[23]  Massimo Midiri,et al.  Multicenter validation of the magnetic resonance t2* technique for segmental and global quantification of myocardial iron , 2009, Journal of magnetic resonance imaging : JMRI.

[24]  Matthew W. Darlison,et al.  Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[25]  J. Goldfarb,et al.  T1‐weighted magnetic resonance imaging shows fatty deposition after myocardial infarction , 2007, Magnetic resonance in medicine.

[26]  D. Pennell,et al.  A Randomized, Placebo-Controlled, Double-Blind Trial of the Effect of Combined Therapy With Deferoxamine and Deferiprone on Myocardial Iron in Thalassemia Major Using Cardiovascular Magnetic Resonance , 2007, Circulation.

[27]  David N. Firmin,et al.  Intercentre Reproducibility of Magnetic Resonance T2* Measurements of Myocardial Iron in Thalassaemia , 2005, The International Journal of Cardiovascular Imaging.

[28]  T. Coates,et al.  MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. , 2005, Blood.

[29]  Thomas D. Coates,et al.  Cardiac Iron Determines Cardiac T2*, T2, and T1 in the Gerbil Model of Iron Cardiomyopathy , 2005, Circulation.

[30]  T. Meade,et al.  Mimicking liver iron overload using liposomal ferritin preparations , 2004, Magnetic resonance in medicine.

[31]  D. Pennell,et al.  A single breath‐hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload , 2003, Journal of magnetic resonance imaging : JMRI.

[32]  D. Rennie,et al.  Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative , 2003, BMJ : British Medical Journal.

[33]  D N Firmin,et al.  Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. , 2001, European heart journal.

[34]  Matthew Darlison,et al.  Survival in β-thalassaemia major in the UK: data from the UK Thalassaemia Register , 2000, The Lancet.

[35]  G. Link,et al.  Pathophysiology of Iron Overload a , 1998, Annals of the New York Academy of Sciences.

[36]  N. Olivieri,et al.  Quantification of cardiac and tissue iron by nuclear magnetic resonance relaxometry in a novel murine thalassemia-cardiac iron overload model. , 1996, The Canadian journal of cardiology.

[37]  R. Fischer,et al.  Liver iron quantification: studies in aqueous iron solutions, iron overloaded rats, and patients with hereditary hemochromatosis. , 1994, Magnetic resonance imaging.

[38]  D. Halperin,et al.  Regression of cardiac insufficiency after ambulatory intravenous deferoxamine in thalassemia major. , 1993, Chest.

[39]  W. Taylor,et al.  Determination of Iron in Cardiac and Liver Tissues by Plasma Emission Spectroscopy , 1987, Annals of clinical biochemistry.

[40]  B. Bacon,et al.  Nuclear magnetic resonance imaging of experimentally induced liver disease. , 1983, Radiology.